Case number 1:19-cv-01251
Teva Pharmaceuticals International GmbH et al v. Lupin, Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 9, 2020 | 1 | Complaint (63) |
| Mar 19, 2020 | 30 | Redacted Document (7) Docket Text: REDACTED VERSION of [24] SO ORDERED,, Terminated Case, by Lupin Pharmaceuticals, Inc., Lupin, Ltd.. (Dorsney, Kenneth) |
| Mar 19, 2020 | 29 | Redacted Document (7) Docket Text: REDACTED VERSION of [23] Stipulation of Dismissal by Lupin Pharmaceuticals, Inc., Lupin, Ltd.. (Dorsney, Kenneth) |
| Mar 18, 2020 | 28 | Order on Motion to Seal Document (1) Docket Text: ORDER granting [26] Motion to Seal Document. Signed by Judge Colm F. Connolly on 3/18/2020. (nmf) |
| Mar 18, 2020 | 27 | Redacted Document (23) Docket Text: REDACTED VERSION of [26] MOTION to Seal Document: Oral Order, by Lupin Pharmaceuticals, Inc., Lupin, Ltd.. (Dorsney, Kenneth) |
| Mar 11, 2020 | 25 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s)US 8,609,707 B2; US 9,000,021 B2; US 9,034,908 B2; US 9,144,568 B1; US 9,265,831 B2; US 9,572,796 B2; US 9,572,797 B2; US 9,572,887 B2; US 9,579,384 B2; US 9,597,397 B2; ) US 9,597,398 B2; US 9,597,399 B2; US 10,010,533 B2; US 10,052,385 B2. (Attachments: # (1) Patent Report Page 2, # (2) Patent Report Page 3)(nmf) |
| Mar 11, 2020 | 25 | Patent Report Page 3 (1) |
| Mar 11, 2020 | 25 | Patent Report Page 2 (1) |
| Mar 11, 2020 | 25 | Patent/Trademark Report to Commissioner (1) |
| Mar 11, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER Although the Court signed the proposed stipulation and order of dismissal, the Court does not understand why the stipulation and order is marked confidential and under seal. Therefore, IT IS HEREBY ORDERED that the stipulation and order shall be unsealed on March 18, 2020 unless at least one of the parties shows good cause to maintain the stipulation and order under seal. Ordered by Judge Colm F. Connolly on 3/11/2020. (nmf) |
| Feb 21, 2020 | 22 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to the Complaint to March 13, 2020 - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Feb 21, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [22] STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to the Complaint to March 13, 2020 filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc. Set/Reset Answer Deadlines: Lupin Pharmaceuticals, Inc. answer due 3/13/2020; Lupin, Ltd. answer due 3/13/2020. Signed by Judge Colm F. Connolly on 2/21/2020. (fms) |
| Feb 14, 2020 | N/A | SO ORDERED (0) |
| Feb 13, 2020 | 21 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to the Complaint to February 21, 2020 - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Feb 7, 2020 | N/A | SO ORDERED (0) |
| Feb 7, 2020 | 20 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to ANSWER, move or otherwise respond to the Complaint to February 14, 2020 - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Keller, Karen) |
| Jan 31, 2020 | N/A | SO ORDERED (0) |
| Jan 30, 2020 | 19 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to the Complaint to February 7, 2020 - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Nov 12, 2019 | N/A | SO ORDERED (0) |
| Nov 11, 2019 | 18 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Defendants Lupin, Ltd. and Lupin Pharmaceuticals, Inc. to answer, move or otherwise respond to the Complaint to January 31, 2020 - filed by Lupin Pharmaceuticals, Inc., Lupin, Ltd.. (Dorsney, Kenneth) |
| Oct 29, 2019 | 17 | Protective Order (23) Docket Text: CORRECTED PROTECTIVE ORDER. Signed by Judge Colm F. Connolly on 10/29/2019. (fms) |
| Oct 21, 2019 | 16 | Motion for Protective Order (23) Docket Text: MOTION for Protective Order [Corrected] - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Oct 16, 2019 | N/A | Deficiency Notice (0) Docket Text: (CLEARED - SEE D.I. [16]) DEFICIENCY NOTICE by the Court issued to counsel re [15] Motion for Protective Order. Any proposed protective order must include the following paragraph: Other Proceedings. By entering this Order and limiting the disclosure of information in this case, the Court does not intend to preclude another court from finding that information may be relevant and subject to disclosure in another case. Any person or party subject to this Order who becomes subject to a motion to disclose another partys information designated as confidential pursuant to this Order shall promptly notify that party of the motion so that the party may have an opportunity to appear and be heard on whether that information should be disclosed. (fms) Modified on 10/22/2019 (fms). |
| Oct 11, 2019 | 15 | Motion for Protective Order (23) Docket Text: (THIS HAS BEEN CORRECTED - SEE D.I. [16]) MOTION for Protective Order - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Keller, Karen) Modified on 10/22/2019 (fms). |
| Jul 18, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Kevin P. Burke,Jeffrey A Marx,Deanne M. Mazzochi,Paul J. Molino,William A. Rakoczy for Lupin Pharmaceuticals, Inc., Lupin, Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lak) |
| Jul 17, 2019 | 14 | SO ORDERED (2) Docket Text: SO ORDERED, re [13] STIPULATION TO EXTEND TIME for Defendants Lupin, Ltd. and Lupin Pharmaceuticals, Inc. to answer, move or otherwise respond to the Complaint to December 2, 2019 filed by Lupin, Ltd., Lupin Pharmaceuticals, Inc. Set/Reset Answer Deadlines: Lupin Pharmaceuticals, Inc. answer due 12/2/2019; Lupin, Ltd. answer due 12/2/2019. Signed by Judge Colm F. Connolly on 7/17/2019. (fms) |
| Jul 15, 2019 | 13 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Defendants Lupin, Ltd. and Lupin Pharmaceuticals, Inc. to answer, move or otherwise respond to the Complaint to December 2, 2019 - filed by Lupin Pharmaceuticals, Inc., Lupin, Ltd.. (Dorsney, Kenneth) |
| Jul 15, 2019 | N/A | Add Attorneys Pro Hac Vice (0) |
| Jul 12, 2019 | 12 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Melvin W. Gaddy - filed by Lupin Pharmaceuticals, Inc., Lupin, Ltd.. (Dorsney, Kenneth) |
| Jul 12, 2019 | N/A | SO ORDERED (0) |
| Jul 11, 2019 | 11 | Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Kevin P. Burke, Attorney Jeffrey A. Marx, Attorney Deanne M. Mazzochi, Attorney Paul J. Molino and Attorney William A. Rakoczy - filed by Lupin Pharmaceuticals, Inc., Lupin, Ltd.. (Dorsney, Kenneth) |
| Jul 11, 2019 | N/A | SO ORDERED (0) |
| Jul 10, 2019 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Jul 3, 2019 | 10 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc., Cephalon, Inc.: For Lupin Pharmaceuticals, Inc. waiver sent on 7/3/2019, answer due 9/3/2019; Lupin, Ltd. waiver sent on 7/3/2019, answer due 9/3/2019. (Hoeschen, Nathan) |
| Jul 3, 2019 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Lupin Pharmaceuticals, Inc. on 7/3/2019; Lupin, Ltd. on 7/3/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmg) |
| Jul 2, 2019 | 9 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate BlackRock, Inc., Other Affiliate Janus Henderson Group PLC for Eagle Pharmaceuticals, Inc. filed by Eagle Pharmaceuticals, Inc. (nmg) |
| Jul 2, 2019 | 8 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceutical Industries Ltd. for Cephalon, Inc. filed by Cephalon, Inc.. (nmg) |
| Jul 2, 2019 | 7 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceutical Industries Ltd. for Teva Pharmaceuticals International GmbH filed by Teva Pharmaceuticals International GmbH. (nmg) |
| Jul 2, 2019 | 6 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,597,398 B2; US 9,597,399 B2; US 10,010,533 B2; US 10,052,385 B2. (nmg) |
| Jul 2, 2019 | 5 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,572,796 B2; US 9,572,797 B2; US 9,572,887 B2; US 9,579,384 B2; US 9,597,397 B2. (nmg) |
| Jul 2, 2019 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,609,707 B2; US 9,000,021 B2; US 9,034,908 B2; US 9,144,568 B1; US 9,265,831 B2. (nmg) |
| Jul 2, 2019 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 5/21/2019. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 11/21/2021. (nmg) |
| Jul 2, 2019 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) |
| Jul 2, 2019 | 1 | Civil Cover Sheet (1) |
| Jul 2, 2019 | 1 | Exhibit N (13) |
| Jul 2, 2019 | 1 | Exhibit M (12) |
| Jul 2, 2019 | 1 | Exhibit L (9) |
| Jul 2, 2019 | 1 | Exhibit K (7) |
| Jul 2, 2019 | 1 | Exhibit J (13) |
| Jul 2, 2019 | 1 | Exhibit I (13) |
| Jul 2, 2019 | 1 | Exhibit H (13) |
| Jul 2, 2019 | 1 | Exhibit G (18) |
| Jul 2, 2019 | 1 | Exhibit F (12) |
| Jul 2, 2019 | 1 | Exhibit E (13) |
| Jul 2, 2019 | 1 | Exhibit D (10) |
| Jul 2, 2019 | 1 | Exhibit C (10) |
| Jul 2, 2019 | 1 | Exhibit B (9) |
| Jul 2, 2019 | 1 | Main Document (63) Docket Text: COMPLAINT for PATENT INFRINGEMENT filed against Lupin Pharmaceuticals, Inc. and Lupin, Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2678396.) - filed by Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc., Cephalon, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Civil Cover Sheet)(nmg) |
| Jul 2, 2019 | 1 | Exhibit A (11) |
| Jul 2, 2019 | 1 | Complaint* (1) |
